Imricor Medical Systems

What Imricor Medical Systems does

Imricor Medical Systems is a Burnsville, Minnesota-based medical device company that develops and commercializes the only commercially available suite of interventional cardiac magnetic resonance (iCMR) products for catheter ablation of cardiac arrhythmias. Founded in 2006 by Steve Wedan — a former GE Healthcare MRI and ultrasound design engineer — the company has spent nearly two decades engineering catheters, recording systems, and mapping platforms that are safe and functional inside the bore of an MRI scanner, eliminating the X-ray fluoroscopy that has historically guided EP procedures.

The product portfolio comprises four integrated components sold as an ecosystem: the Vision-MR Ablation Catheter 2.0 and Vision-MR Diagnostic Catheter (the only MR-compatible ablation and diagnostic EP catheters with active MR tracking), the Advantage-MR EP Recorder/Stimulator (an MR-conditional EP amplifier and cardiac stimulator), and the NorthStar Mapping System (the first and only MRI-Native 3D mapping and guidance system, FDA-cleared in February 2026). Accessories include the Vision-MR Dispersive Electrode. The platform enables real-time visualization of cardiac anatomy, catheter position, and lesion formation during ablation, addressing the principal limitations of X-ray-guided EP — poor soft tissue contrast, ionizing radiation exposure, and inability to assess lesion quality intra-procedure.

The company generates revenue through capital equipment sales (mapping systems, recorders) and recurring disposable catheter sales to hospitals and academic cardiac centers performing EP procedures. Customers are major institutions including Leipzig Heart Centre, Amsterdam UMC, Charité, Haga Hospital, Semmelweis University, CHUV, Johns Hopkins, and UVA Health, with more than 11 active iCMR sites across Europe, the Middle East, Australia/New Zealand, and now the United States following the April 2026 U.S. commercial launch. Distribution combines direct sales (particularly in the U.S.) with regional channel partners (Philips, NordicNeuroLab, Sana Einkauf & Logistik, Regional Health Care Group, FMS Saudi Arabia), and the technology is integrated with MRI scanners from GE HealthCare, Siemens Healthineers, and Philips. The company is publicly listed on the ASX (IMR) and remains in a capital-intensive growth phase, having raised approximately A$68M cumulatively through multiple rounds, including a ~A$43M placement in May 2026 to fund U.S. commercialization.

Name

Imricor Medical Systems

Legal name

Imricor Medical Systems, Inc.

Website

https://imricor.com

Company type

Public

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Imricor Medical Systems develops the only commercially available MRI-compatible electrophysiology products for cardiac ablation — including catheters, a 3D mapping system, and EP recorders — selling to hospitals and academic medical centers performing arrhythmia treatment.

Ownership category

akta.pro rank

Product category

Cardiac Electrophysiology Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Electrophysiology Mapping & Ablation Systems (HLAHAFAD)

Keywords

• MRI-guided cardiac ablation
• Electrophysiology devices
• MR-compatible catheters
• Cardiac mapping systems
• Interventional cardiac MRI

Headquarters

HQ city

Minneapolis

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations, Others

Revenue model

1. Medical Device Sales: Sale of proprietary MRI-compatible catheters (ablation and diagnostic), EP recorder/stimulator systems, and mapping systems to hospitals and cardiac ablation centers. Revenue generated through direct equipment sales and ongoing disposable catheter products.
2. Disposable Products: Single-use catheters and disposable products consumed during each procedure, providing recurring revenue from established customer sites.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

Imricor develops and manufactures an integrated ecosystem of magnetic resonance imaging (MRI)-compatible electrophysiology devices, including MR-conditional ablation and diagnostic catheters, a 3D mapping and guidance system, and an EP recorder/stimulator. The company's iCMR (interventional cardiac MRI) platform enables physicians to perform real-time, radiation-free cardiac ablation procedures for arrhythmias such as atrial flutter, atrial fibrillation, and ventricular tachycardia.

Product overview

Imricor Medical Systems offers an integrated ecosystem of MRI-compatible (iCMR) products for cardiac ablation procedures. The portfolio consists of the Vision-MR Ablation Catheter 2.0 (the first and only MR-compatible ablation catheter with active tracking), the Vision-MR Diagnostic Catheter (first and only MR-compatible diagnostic catheter), the Advantage-MR EP Recorder/Stimulator (electrophysiology recording and stimulation system), and the NorthStar Mapping System (3D mapping and guidance platform). The Vision-MR Dispersive Electrode completes the accessory line. All products are designed for use within interventional MRI environments, enabling real-time soft tissue visualization during cardiac procedures without X-ray radiation.

Differentiator

Problem solved

Functional benefit

Brands

• iCMR: Interventional Cardiovascular Magnetic Resonance - the company's core technology platform enabling real-time MRI-guided cardiac ablation procedures
• Vision-MR
• NorthStar Mapping System
• Advantage-MR EP Recorder/Stimulator

Products and services

• Vision-MR Ablation Catheter 2.0 The first and only MR-compatible cardiac ablation catheter with patented technology enabling safe, real-time ablation during active MRI scanning. Features active MR tracking, fiber optic tip temperature sensing, enhanced deflection control, and comes in two curve sizes (32mm and 48mm). Single-use RF ablation catheter with 9.5Fr bipole irrigated-tip design.
• Vision-MR Diagnostic Catheter The first and only MR-compatible diagnostic catheter enabling safe, real-time electrophysiological mapping during active MRI scanning. Features active MR tracking with one MR receive coil in the distal end. 9Fr catheter with atraumatic smooth tip for diagnostic procedures.
• Advantage-MR EP Recorder / Stimulator An electrophysiology amplifier and recording system with integrated cardiac stimulator for use within the iCMR environment. Combines a conventional EP recording system with cardiac stimulator functionality to display and record intracardiac electrograms, pacing, and tip temperature monitoring during MRI-guided ablation.
• NorthStar Mapping System First and only cardiac mapping and guidance system designed specifically to harness MR imaging for real-time visualization during minimally-invasive procedures. Provides real-time visibility of anatomy, catheters, and lesion formation with 3D shell display, ablation point tracking, real-time device tracking, and electrophysiology integration.
• Vision-MR Dispersive Electrode An accessory dispersive electrode designed to minimize eddy currents induced on conductive pads during MR scanning. CE marked for use with MRI-guided cardiac ablation procedures.

Quantifiable outcome

• 100% chronic success rate in clinical study for type 1 atrial flutter treatment
• +3 more outcomes

Named customers9 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature6 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Amsterdam University Medical CentrecoreStrategic or Co-development Partner · 4 November 2025Clinical collaboration for first in human ischemic VT ablation under real-time MRI guidance, representing world-first procedural achievements.
• ADIScoreStrategic or Co-development Partner · 29 November 2023Joint Development Agreement for AI modules in NorthStar Mapping System, adding artificial intelligence capabilities to the mapping platform.
• FMS (Saudi Arabia)minorChannel Partner/ Reseller/ Distributor · 31 July 2023Landmark distribution agreement with leading distributor in Saudi Arabia for Middle East market expansion.
• GE HealthCarecoreStrategic or Co-development Partner · 25 January 2023Memorandum of Understanding signed for collaboration in interventional cardiac MRI. GE HealthCare is a major MRI scanner manufacturer, making this partnership critical for integrating Imricor's iCMR products with GE's imaging platforms.
• Siemens HealthineerscoreStrategic or Co-development Partner · 11 August 2022Signed agreement enabling 3D mapping system integration with Siemens MRI scanners. Strategic relationship to improve cardiac ablations by combining real-time MRI with 3D-guided navigation.
• MIPMminorStrategic or Co-development Partner · 31 March 2022Development agreement with MIPM for advancing interventional MRI technology for cardiac procedures.
• NordicNeuroLabminorChannel Partner/ Reseller/ Distributor · 30 August 2021Sales agreement covering Nordic markets for Imricor's MRI-guided cardiac ablation products.
• Regional Health Care GroupminorChannel Partner/ Reseller/ Distributor · 2 April 2021Distribution agreement expanding reach to Australia and New Zealand for the full Imricor product portfolio.
• PhilipsminorChannel Partner/ Reseller/ Distributor · 4 August 2020First sales collaboration agreement with Philips for MRI-guided cardiac ablation products. Philips is a major healthcare technology company.
• Sana Einkauf & LogistikminorChannel Partner/ Reseller/ Distributor · 6 May 2020Master Purchasing Agreement with Sana, Germany's largest group purchasing organization, facilitating access to German hospital networks.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Biosense Webster: Johnson & Johnson's electrophysiology division and the global market leader in catheter ablation and 3D cardiac mapping (CARTO system). Direct peer to Imricor in cardiac ablation, with much broader commercial reach but no MRI-compatible offering.
• Abbott: Major electrophysiology player offering the EnSite X 3D cardiac mapping system and ablation catheters across all major arrhythmia indications. Direct competitor to Imricor in cardiac ablation; significantly larger scale and broader product portfolio.
• Boston Scientific: Established EP competitor with the Rhythmia mapping system and a full ablation catheter portfolio, including recent expansion into pulsed-field ablation. Direct peer to Imricor in cardiac ablation technology and target customers.
• Medtronic: Diversified cardiac device leader with a strong electrophysiology franchise, including cryoablation and the Affera mapping and ablation platform. Direct competitor in EP ablation and a key source of Imricor's executive talent.

Emerging players

• Stereotaxis: Public small-cap developing robotic magnetic navigation systems for cardiac ablation. Smaller and earlier-stage than the EP majors, with an alternative technology approach to the same electrophysiology procedures Imricor targets.
• Acutus Medical: Electrophysiology company developing non-contact mapping and ablation technologies for arrhythmias. Comparable in scale and stage to Imricor, focused on the same EP procedure market but with a different technological approach (ultrasound vs. MRI).
• CathVision: Developer of advanced EP recording systems (ECGenius) used during cardiac ablation procedures. Adjacent technology overlap with Imricor's Advantage-MR EP Recorder/Stimulator for signal acquisition during ablation.

Broad incumbents

• Philips: Major healthcare technology and MRI manufacturer with which Imricor has a sales collaboration. Comparable in that Philips is a critical partner/channels for iCMR procedures through its MRI installed base and broader image-guided therapy portfolio.
• Siemens Healthineers: Global MRI and image-guided therapy leader with which Imricor has a 3D mapping integration agreement. Comparable as both partner and potential competitive platform incumbent in the MRI-based interventional environment.
• GE HealthCare: Major MRI scanner manufacturer (led by Steve Wedan's former employer) with which Imricor has an MoU for interventional cardiac MRI collaboration. Comparable as both a strategic channel partner and incumbent imaging platform whose installed base determines Imricor's accessible market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

• Xx.com/imricor
• Facebookfacebook.com/1047703618416651
• LinkedInlinkedin.com/company/imricor
• Instagraminstagram.com/imricor

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds11 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Imricor Medical Systems